News
Hosted on MSN2mon
Merck’s $8 Billion Cancer Vaccine Faces First US Trial(Bloomberg) -- Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the ...
Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or Pneumococcal 21-valent Conjugate Vaccine, for active ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results